Alzheimer’s Disease: Where Do We Stand Now? - 0513-0000-17-077-H01-P

Alzheimer’s Disease: Where Do We Stand Now?

by Trisha Bogucki, PharmD and Esther Kim, PharmD
0513-0000-17-077-H01-P
(4.6 / 262 ratings )

This course is credentialed for:
Pharmacy (2.00 Contact Hr)

Summary:

The treatment approach to managing patients with dementia caused by Alzheimer’s disease (AD) is only through symptom control. The pathophysiology is not entirely known, and there is no drug available to prevent or cure the disorder. All FDA-approved drugs work by modulating neurotransmitters, either acetylcholine or glutamate. The two basic classes of drugs used to manage symptoms of AD are acetylcholinesterase inhibitors (AcHEI) and partial N-methyl-D-aspartate (NMDA) receptor antagonists. In addition, medications to control mood and behavior are used. These drugs are used to relieve depression, agitation, and insomnia, and include antidepressants, neuroleptics, anxiolytics, and anticonvulsants. As more research is completed and data collected, possible links to genetics, nutrition, and chemical entities may provide insight into future modes of therapy.

Objectives:

The goal of this dementia caused by Alzheimer’s disease (AD) continuing education program is to provide pharmacists and physicians with knowledge about the clinical aspects of managing patients with AD. After studying the information presented here, you will be able to:
  • Describe the approved drugs used to treat patients with AD
  • List the available drug treatments for secondary features of AD
  • Discuss supplements and nonpharmacologic interventions used in managing symptoms of AD
  • Review emerging therapies and areas of research for AD
 

 
Accreditation Information
 
This course is intended for multiple professions, including pharmacists, pharmacy techs, and physicians.
 
Pharmacists: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at ContinuingEducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
 
Type of Activity: Knowledge
 
Initial Release Date: 03/27/2017; Planned Expiration Date: 03/27/2020